Review of Anaesthesia and Analgesia in Patients with COVID-19 in Brazil
Q: Is the topic relevant to the journal area of interest? Is it contemporary and interesting for
Abstract & Keywords
Q: Are all required components included in the abstract? Are the keywords appropriately chosen?
Q: Is the goal explicitly stated in the Introduction? Is its formulation clear and unambiguous?
Q: Is the paper's structure coherent? Is it in coherence with the goal of the paper?
Tools and Methods
Q: Are methods the author uses adequate and well used?
Discussion & Conclusion
Q: Is it related to the results presented before? Do you consider them as coherent?
Comments: In conclusion, the 1st sentence must be reframed as “the pandemic scenario causes both rapid technological and scientific advances in order to find solutions to the problems which arise as a result of SARS-CoV-2 and, in accordance with this situation, there should exist an efficient administration of drugs”
Q: Does the author utilize relevant literature?
Q: What is the level of the author’s knowledge? Does the author utilize all recent contributions relevant to the topic?
Q: Is the length of the paper adequate to the significance of the topic? Do you suggest shortening the paper without losing its value?
Figures & Tables
Q: Does the author use them suitably? Are legend and notations clear?
A: Not applicable.
Q: Is it clear and understandable?
Comments: Except in a few places the sentences were not framed properly.
Further comments on the paper
Comments: The study provides a detailed account on different classes of anaesthetic and analgesic drugs that can be used for the management of COVID-19 patients in cases of intubation and mechanical ventilation in Brazil. This review discusses the broad range of drugs based on the clinical indications, pharmacological characteristics, pharmacokinetics, pharmacodynamics, and possible side effects; in addition, it also illustrates the particularities of the drugs when administered in COVID-19 patients. Lastly, it states that more in-depth studies are required on specific action of each drug in order to determine possible implementation in its administrations in COVID-19 patients.
Q: Would you recommend this manuscript for further publication?
A: Yes - Suitable to be published
If you have any questions and clarifications you can write to the journal.
Science Repository Team
This email is restricted to the intended user.
|Science Repository - Support|
Mônica Santos de Melo Júlia Ferreira Nogueira Lucas Vinicius Andrade dos Santos Luis Claudio Bettamio de Sousa Raiane Nascimento Santana Weslly Jonas Severo da Silva Wictor Hugo de Souza Silva Makson Gleydson Brito de Oliveira
Corresponding AuthorMakson Gleydson Brito de Oliveira
Department of Medicine, Federal University of Sergipe, Lagarto, Sergipe, Brazil
Article TypeReview Article
Publication historyReceived: Tue 11, Aug 2020
Accepted: Tue 25, Aug 2020
Published: Tue 08, Sep 2020
Copyright© 2021 Makson Gleydson Brito de Oliveira. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.